title: [Clinical efficacy of porcine pulmonary surfactant combined with budesonide suspension intratracheal instillation in the treatment of neonatal meconium aspiration syndrome].
abstract: OBJECTIVE
  To study the clinical efficacy of porcine pulmonary surfactant (PS) combined with budesonide suspension intratracheal instillation in the treatment of neonatal meconium aspiration syndrome (MAS).
  
  
  METHODS
  Seventy neonates with MAS were enrolled for a prospective study. The neonates were randomly assigned to PS alone treatment group and PS+budesonide treatment group (n=35 each). The PS alone treatment group was given PS (100 mg/kg) by intratracheal instillation. The treatment group was given budesonide suspension (0.25 mg/kg) combined with PS (100 mg/kg).
  
  
  RESULTS
  The rate of repeated use of PS in the PS+ budesonide group was significantly lower than that in the PS alone group 12 hours after treatment (p<0.05). The improvement of PaO2/FiO2, TcSaO2, PaO2, and PaCO2in the PS+ budesonide group was significantly greater than that in the PS alone group 6, 12, and 24 hours after treatment (p<0.05). The chest X-ray examination showed that the pulmonary inflammation absorption in the PS+ budesonide group was significantly better than that in the PS alone group 48 hours after treatment (p<0.05). The incidence of complications in the PS+budesonide group was significantly lower than that in the PS alone group (p<0.05), and the average hospitalization duration was significantly shorter than that in the PS alone group (p<0.01).
  
  
  CONCLUSIONS
  PS combined with budesonide suspension intratracheal instillation for the treatment of neonatal MAS is effective and superior to PS alone treatment.
authors.affiliation: Department of Neonatology, The 6th People's Hospital of Foshan Nanhai District, Foshan, Guangdong 528248, China. 275828141@qq.com.
authors.forename: Xiu-Zhen
authors.initials: XZ
authors.lastname: Tan
authors.forename: Shi-Guang
authors.initials: SG
authors.lastname: Wu
authors.forename: Jian-Hua
authors.initials: JH
authors.lastname: Zhang
authors.forename: Xiao-Fen
authors.initials: XF
authors.lastname: Li
authors.forename: Ping-Ming
authors.initials: PM
authors.lastname: Gao
authors.forename: Yu
authors.initials: Y
authors.lastname: Wang
mesh_terms: D000818:Animals; D019819:Budesonide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007902:Length of Stay; D008297:Male; D008471:Meconium Aspiration Syndrome / Q000150:complications / Q000188:drug therapy*; D011446:Prospective Studies; D011663:Pulmonary Surfactants / Q000008:administration & dosage*; D013535:Suspensions; D013552:Swine; D014132:Trachea
chemical_list: D011663:Pulmonary Surfactants; D013535:Suspensions; D019819:Budesonide